Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo

J Ethnopharmacol. 2010 Sep 15;131(2):433-42. doi: 10.1016/j.jep.2010.07.008. Epub 2010 Jul 13.

Abstract

Ethnopharmacological relevance: A traditional herb, Yi-Gan San, has been widely used for the management of neurodegenerative disorders in traditional East Asian Medicine.

Aim of the study: The present study investigated the neuroprotective effects of Yi-Gan San in 1-methyl-4-phenylpyridine/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cytotoxicity in vitro and in vivo and sought to clarify its underlying mechanisms.

Materials and methods: The effect of Yi-Gan San on 1-methyl-4-phenylpyridine was measured in terms of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assays, caspase-3 activity, and western blot analysis of phosphorylated Akt, one of the survival-related signaling proteins in SH-SY5Y cells. The effects of Yi-Gan San were also confirmed in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonian mouse model using a rotarod test and tyrosine hydroxylase-immunohistochemistry.

Results: Pretreatment of Yi-Gan San with 1-methyl-4-phenylpyridine showed a significant protective effect on SH-SY5Y cells and significantly decreased the level of caspase-3 activity compared to the values for the 1-methyl-4-phenylpyridine-treated cells. This process increased the protein expressions of phosphorylated Akt, and an inhibitor of phosphatidylinositol 3-kinase (PI3K)/Akt, LY294002, significantly decreased this protective effect of Yi-Gan San. In the mouse Parkinson's disease model, treatment with Yi-Gan San also significantly improved motor functioning and prevented dopaminergic loss related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine challenge.

Conclusion: Using both in vitro and in vivo methods, this study revealed that Yi-Gan San has neuroprotective effects and rescues dopaminergic neurons from 1-methyl-4-phenylpyridine/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity, possibly via the PI3K/Akt pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / analogs & derivatives
  • 1-Methyl-4-phenylpyridinium
  • Animals
  • Caspase 3 / metabolism*
  • Cell Line, Tumor
  • Chromones / pharmacology
  • Cytotoxins
  • Disease Models, Animal
  • Dopamine / metabolism
  • Drugs, Chinese Herbal / pharmacology
  • Drugs, Chinese Herbal / therapeutic use*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Magnoliopsida*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Morpholines / pharmacology
  • Motor Activity / drug effects
  • Neuroblastoma / metabolism
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / metabolism
  • Phosphorylation
  • Phytotherapy*
  • Proto-Oncogene Proteins c-akt / metabolism

Substances

  • Chromones
  • Cytotoxins
  • Drugs, Chinese Herbal
  • Enzyme Inhibitors
  • Morpholines
  • Neuroprotective Agents
  • Yi-Gan San
  • 4-phenyl-1,2,3,6-tetrahydropyridine
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Proto-Oncogene Proteins c-akt
  • Caspase 3
  • 1-Methyl-4-phenylpyridinium
  • Dopamine